NuCana plc - American Depositary Share (NCNA): Price and Financial Metrics
NCNA Price/Volume Stats
| Current price | $0.04 | 52-week high | $10.79 |
| Prev. close | $0.05 | 52-week low | $0.03 |
| Day low | $0.04 | Volume | 116,940,300 |
| Day high | $0.06 | Avg. volume | 20,416,805 |
| 50-day MA | $0.67 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 248.83K |
NCNA Stock Price Chart Interactive Chart >
NuCana plc - American Depositary Share (NCNA) Company Bio
NuCana plc develops anti-cancer medicines for ovarian, biliary, pancreatic, colorectal, haematology, oncology, and breast cancers. NuCana produces oncology medicines using a proprietary technology platform for cancer patients. The company was incorporated in 1997 and is based in Edinburgh, the United Kingdom.
NCNA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -96.99% |
| 1-year | -98.88% |
| 3-year | -99.73% |
| 5-year | -99.97% |
| YTD | -96.64% |
| 2024 | -83.91% |
| 2023 | -55.18% |
| 2022 | -72.27% |
| 2021 | -46.99% |
| 2020 | -26.39% |
Loading social stream, please wait...